News

Boehringer Ingelheim with its US animal health business Boehringer Ingelheim Vetmedica, has entered into an agreement with Pfizer to acquire certain assets of Wyeth Pharmaceutical’s Fort Dodge Animal

AIDS Healthcare Foundation (AHF) has disclosed its plans to open its first AIDS treatment center in Washington, DC, on September 24, 2009. AHF’s health care center, to be

ACTEGA Rhenania has developed a novel series of solvent-free polyurethane adhesives for laminates to be used in packaging. Compared to classical solvent-borne polyurethane adhesives there is no need

Nycomed will invest in a state-of-the-art pharmaceutical production plant near the city of Yaroslavl in Russia. The company plans to invest between E65m to E75m. The company said

Nektar Therapeutics presented positive data on lead oncology program, NKTR-102, demonstrating encouraging phase 1 and preclinical anti-tumor activity of the investigational compound in ovarian cancer. These data were

Ion Beam Applications SA (IBA) and Aposense has entered into an collaboration agreement for commercialising Aposense [18F]–ML-10, Aposense’s novel agent for molecular imaging of apoptosis. The agreement includes

QIAGEN has acquired DxS, a privately-held developer and manufacturer of companion diagnostic products headquartered in Manchester, UK. The transaction is valued at approximately $95m in cash, plus up

Amgen has revealed detailed results from the phase 3 181 trial evaluating Vectibix in combination with Folfiri, as a second-line treatment for metastatic colorectal cancer. In this trial,

SoBran has signed a multi-year contract to provide managerial and supervisory personnel for the University of Texas Southwestern Medical Center in Dallas, TX. Under this contract SoBran will